IL6 and metabolic dysfunction-associated steatotic liver disease: Previous research has demonstrated a positive correlation between IL-6 levels and systemic insulin resistance, IL-6 expression in the liver, liver inflammation, and the degree of fibrosis in patients with NAFLD [38,39,40].